Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.54B |
| 2 |
Apple
AAPL
|
+$5.8B |
| 3 |
Amazon
AMZN
|
+$3.28B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.19B |
| 5 |
Mastercard
MA
|
+$3.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$380M |
| 2 |
Twilio
TWLO
|
+$357M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$329M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.7% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
651
DELISTED
Citrix Systems Inc
CTXS
| $22.1M | 0.01% |
213,112
+125,910
| +144% | +$12.9M |
|
652
Corcept Therapeutics
CORT
$9.98B
| $21.9M | 0.01% |
854,326
+701,815
| +460% | +$18.8M |
|
653
Yeti Holdings
YETI
$3.87B
| $21.8M | 0.01% |
763,558
+737,029
| +2,778% | +$30.7M |
|
|
ZIMV
654
DELISTED
ZimVie
ZIMV
| $21.5M | 0.01% |
2,181,712
+1,059,733
| +94% | +$17.1M |
|
655
Health Catalyst
HCAT
$160M
| $21.5M | 0.01% |
2,218,438
+992,197
| +81% | +$13.1M |
|
656
Medpace
MEDP
$16.3B
| $21.3M | 0.01% |
135,396
+114,905
| +561% | +$18.3M |
|
657
4D Molecular Therapeutics
FDMT
$502M
| $21.2M | 0.01% |
2,639,462
+1,304,414
| +98% | +$11.8M |
|
|
KVSC
658
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $21.2M | 0.01% |
2,170,722
+1,970,387
| +984% | +$19.3M |
|
659
Fidelity National Financial
FNF
$14.4B
| $21.2M | 0.01% |
609,282
+390,820
| +179% | +$14.6M |
|
|
ITCI
660
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $21.1M | 0.01% |
453,482
+265,431
| +141% | +$13.9M |
|
661
HDFC Bank
HDB
$123B
| $21.1M | 0.01% |
721,160
+341,352
| +90% | +$10.5M |
|
662
West Fraser Timber
WFG
$5.21B
| $21M | 0.01% |
288,200
+102,359
| +55% | +$8.88M |
|
663
Expensify
EXFY
$174M
| $20.9M | 0.01% |
1,407,804
+703,902
| +100% | +$13.1M |
|
664
Phreesia
PHR
$689M
| $20.9M | 0.01% |
821,174
+410,593
| +100% | +$10.2M |
|
665
Consolidated Edison
ED
$41.4B
| $20.9M | 0.01% |
243,280
+157,728
| +184% | +$15.2M |
|
666
First American
FAF
$7.98B
| $20.8M | 0.01% |
450,066
+139,786
| +45% | +$7.56M |
|
667
MGIC Investment
MTG
$6.47B
| $20.7M | 0.01% |
1,615,330
-1,874,877
| -54% | -$26.2M |
|
668
Dominion Energy
D
$62B
| $20.4M | 0.01% |
294,774
+118,547
| +67% | +$9.57M |
|
|
Y
669
DELISTED
Alleghany Corp
Y
| $20.3M | 0.01% |
24,206
+13,602
| +128% | +$11.4M |
|
670
IDEAYA Biosciences
IDYA
$3.43B
| $20.3M | 0.01% |
1,362,354
+1,066,187
| +360% | +$13.8M |
|
671
FormFactor
FORM
$6.51B
| $20.3M | 0.01% |
810,876
+248,385
| +44% | +$8.06M |
|
|
VIVO
672
DELISTED
Meridian Bioscience Inc
VIVO
| $20.1M | 0.01% |
637,802
+592,913
| +1,321% | +$19.2M |
|
673
Cigna
CI
$78.4B
| $20.1M | 0.01% |
72,250
+33,325
| +86% | +$9.38M |
|
|
STOR
674
DELISTED
STORE Capital Corporation
STOR
| $20M | 0.01% |
639,744
+442,031
| +224% | +$12.6M |
|
675
Blackrock
BLK
$167B
| $20M | 0.01% |
36,352
+16,983
| +88% | +$11.1M |
|
Similar funds
Janus Henderson Group's Q3 2022 Portfolio in Review
As of Q3 2022, Janus Henderson Group held 2,740 positions worth $267B, up 84% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group deployed $142B of net new capital in Q3 2022, opening 150 new positions and adding to 2,084 existing holdings. Its largest new stake was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Snap, an estimated $380M trimmed.
- Janus Henderson Group's largest Q3 2022 buy was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
- Janus Henderson Group added most to Microsoft in Q3 2022, an estimated $8.54B increase.
- Janus Henderson Group's biggest Q3 2022 reduction was Snap, cutting an estimated $380M.
- Janus Henderson Group fully exited Alibaba in Q3 2022, selling an estimated $65.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $267B portfolio in Q3 2022.
- Janus Henderson Group opened 150 new positions and closed 205 in Q3 2022.
- Janus Henderson Group's portfolio value rose 84% quarter-over-quarter to $267B.
Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.